Hearing News Watch

FARMINGTON HILLS, MICHIGAN — The International Hearing Society (IHS) is marking its 75th anniversary in 2026, recognizing its longstanding role in supporting hearing healthcare professionals who provide hearing evaluations and hearing aid services. The anniversary will be celebrated under the theme “Uniting Generations, Advancing Hearing Care,” with a focus on advocacy, relationships, communication, and education. According to the organization, these areas

HELSINKI, FINLAND — Deafmetal, a Finnish design-driven hearing health company focused on hearing aid jewelry and accessories, has announced the launch of a new Audiology Clinic Program alongside a €500,000 seed funding round to support international growth. The company’s approach centers on addressing one of the longstanding challenges in hearing care—adoption. According to the World Health Organization, only an estimated

SOMERSET, NEW JERSEY — The Oticon Hearing Foundation is continuing its partnership with the American Academy of Audiology Foundation (AAAF) through a $30,000 contribution aimed at supporting the professional development and humanitarian engagement of future audiologists. For the 2026–27 academic year, the Foundation will provide $20,000 toward student scholarships and up to $10,000 to support two student humanitarian mission trips

SCHAUMBURG, ILLINOIS — Natus Sensory, a global provider of sensory and diagnostic solutions, has announced a new strategic distribution partnership with Oaktree Products, a second-generation family-owned distributor of clinical supplies and diagnostic equipment serving the hearing healthcare industry. According to the companies, the partnership is intended to broaden access to Natus Sensory’s diagnostic hearing assessment and fitting solutions across the

MILAN, ITALY — Amplifon, parent company of Miracle-Ear and a global leader in hearing care services, today announced the appointment of Dr. Nicholas Reed to the newly created role of Vice President of Audiology Innovation and Research. In this role, Dr. Reed will oversee Amplifon’s research initiatives and support the company’s broader efforts in audiology and hearing health. He joins

AMSTERDAM, THE NETHERLANDS — Norgine B.V. announced that Swissmedic has granted marketing authorization for PEDMARQSI® (sodium thiosulfate solution for infusion) for the prevention of cisplatin-induced ototoxicity (hearing loss) in patients aged 1 month to <18 years with localized, non-metastatic solid tumors. The approval provides an authorized treatment option in an area of significant unmet medical need for children receiving cisplatin chemotherapy.

MONTPELLIER, FRANCE — Sensorion on Monday reported updated six-month efficacy data from Cohort 2 of its Phase 1/2 Audiogene trial evaluating SENS-501, while also providing a development update on its GJB2 gene therapy program, GJB2-GT (SENS-601). The company said the six-month follow-up data from Cohort 2 showed sustained early efficacy signals in two of three patients treated with the higher

OKLAHOMA CITY, OK — When people cannot hear their own voices, their tongue movements become less precise during speech, according to new research from the University of Oklahoma. The findings provide direct evidence of how hearing contributes to speech production and may help inform therapies for individuals with hearing loss or those affected by conditions such as tongue cancer. The

Organizers of the International Congress of Hearing Care Professionals (EUHA 2026) have announced that The Netherlands will serve as the partner country for this year’s event, taking place October 14–16, 2026, in Hanover, Germany. The partner country concept includes a range of program elements and activities that will be featured throughout the three-day congress. Planned highlights include expert presentations from

GN Store Nord A/S announced that it has entered into a definitive agreement to sell its Hearing business to Amplifon S.p.A., a global hearing care retailer. The transaction values the Hearing business at DKK 17.0 billion (~$2.5 billion USD)1 on a cash-free and debt-free basis. The deal will be settled with DKK 12.6 billion (~$1.85 billion USD)2 in cash and